KENYON LAWRENCE A

EVP, Chief Financial Officer at PAR PHARMACEUTICAL COMPANIES, INC. · on record since Jan 12, 2010
Chief Financial Officer at Outlook Therapeutics, Inc. · on record since Sep 18, 2018
Former EVP and CFO at PAR PHARMACEUTICAL COMPANIES, INC. · on record since Aug 4, 2010
President, CEO and CFO at ALFACELL CORP · on record since Jul 25, 2012
Chief Financial Officer at LAURIER INTERNATIONAL INC · on record since Feb 26, 2014
Director at Outlook Therapeutics, Inc. · on record since Sep 18, 2018
CFO and Secretary at NEOPHARM INC · on record since May 2, 2005

Insider trading activity of KENYON LAWRENCE A

Transactions on record: 53; since Feb 18, 2004

Open-market buys: 9; $122.6K

Open-market sells: 21; $581K

Companies traded: 5; last filing Sep 30, 2024

Figures computed from official regulatory filings — methodology.

Companies where KENYON LAWRENCE A has traded

Outlook Therapeutics, Inc.14 tx · $109.9K · Sep 30, 2024
LAURIER INTERNATIONAL INC1 tx · Feb 26, 2014
ALFACELL CORP8 tx · $53.4K · Jul 25, 2012
PAR PHARMACEUTICAL COMPANIES, INC.27 tx · $1M · Aug 4, 2010
NEOPHARM INC3 tx · Jan 27, 2006

Track record of KENYON LAWRENCE A

Statistical track record

Free

Open-market buys: 9

Last buy: Sep 26, 2024

Win rates and median returns are available with a free account (5 insiders/month).

Create a free account

Transaction history of KENYON LAWRENCE A

Co-insiders of KENYON LAWRENCE A

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Outlook Therapeutics, Inc.	Sep 30, 2024	Buy	5,000	5.69 USD	$28.5K	SEC
Outlook Therapeutics, Inc.	Mar 22, 2024	AwardD	12,500	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Apr 20, 2021	Buy	10,000	1.83 USD	$18.3K	SEC
Outlook Therapeutics, Inc.	Oct 5, 2020	AwardD	3,668,984	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Jul 21, 2020	AwardD	450,000	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Mar 20, 2020	AwardD	216,435	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Oct 15, 2019	Sell	-1,350	1.70 USD	$2.3K	SEC
Outlook Therapeutics, Inc.	Sep 13, 2019	AwardD	450,000	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Feb 19, 2019	AwardD	800,000	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Feb 8, 2019	Buy	25,000	0.90 USD	$22.5K	SEC
Outlook Therapeutics, Inc.	Sep 18, 2018	Sell	-10,100	0.87 USD	$8.8K	SEC
Outlook Therapeutics, Inc.	Aug 3, 2018	AwardD	500,000	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Dec 26, 2017	Sell	-26,165	1.13 USD	$29.6K	SEC
Outlook Therapeutics, Inc.	Dec 22, 2016	Award	50,000	0.00 USD	$0	SEC
LAURIER INTERNATIONAL INC	Feb 26, 2014	AwardD	223,445	0.00 USD	$0	SEC
ALFACELL CORP	Jul 25, 2012	AwardD	400,000	0.00 USD	$0	SEC
PAR PHARMACEUTICAL COMPANIES, INC.	Aug 4, 2010	Other	-6,312	26.90	$169.8K	SEC
PAR PHARMACEUTICAL COMPANIES, INC.	Mar 3, 2010	Sell	-200	25.22	$5K	SEC
PAR PHARMACEUTICAL COMPANIES, INC.	Mar 3, 2010	Sell	-100	25.25	$2.5K	SEC
PAR PHARMACEUTICAL COMPANIES, INC.	Mar 3, 2010	Sell	-400	25.26	$10.1K	SEC
PAR PHARMACEUTICAL COMPANIES, INC.	Mar 3, 2010	ExerciseD	-21,439	0.00	$0	SEC
PAR PHARMACEUTICAL COMPANIES, INC.	Mar 3, 2010	Exercise	21,439	13.06	$280K	SEC
PAR PHARMACEUTICAL COMPANIES, INC.	Mar 3, 2010	Sell	-500	25.20	$12.6K	SEC
PAR PHARMACEUTICAL COMPANIES, INC.	Mar 3, 2010	Sell	-700	25.19	$17.6K	SEC
PAR PHARMACEUTICAL COMPANIES, INC.	Mar 3, 2010	Sell	-3,261	25.19	$82.1K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Outlook Therapeutics, Inc.	Sep 30, 2024	Buy	5,000	5.69 USD	$28.5K	SEC
Outlook Therapeutics, Inc.	Mar 22, 2024	AwardD	12,500	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Apr 20, 2021	Buy	10,000	1.83 USD	$18.3K	SEC
Outlook Therapeutics, Inc.	Oct 5, 2020	AwardD	3,668,984	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Jul 21, 2020	AwardD	450,000	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Mar 20, 2020	AwardD	216,435	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Oct 15, 2019	Sell	-1,350	1.70 USD	$2.3K	SEC
Outlook Therapeutics, Inc.	Sep 13, 2019	AwardD	450,000	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Feb 19, 2019	AwardD	800,000	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Feb 8, 2019	Buy	25,000	0.90 USD	$22.5K	SEC
Outlook Therapeutics, Inc.	Sep 18, 2018	Sell	-10,100	0.87 USD	$8.8K	SEC
Outlook Therapeutics, Inc.	Aug 3, 2018	AwardD	500,000	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Dec 26, 2017	Sell	-26,165	1.13 USD	$29.6K	SEC
Outlook Therapeutics, Inc.	Dec 22, 2016	Award	50,000	0.00 USD	$0	SEC
LAURIER INTERNATIONAL INC	Feb 26, 2014	AwardD	223,445	0.00 USD	$0	SEC
ALFACELL CORP	Jul 25, 2012	AwardD	400,000	0.00 USD	$0	SEC
PAR PHARMACEUTICAL COMPANIES, INC.	Aug 4, 2010	Other	-6,312	26.90	$169.8K	SEC
PAR PHARMACEUTICAL COMPANIES, INC.	Mar 3, 2010	Sell	-200	25.22	$5K	SEC
PAR PHARMACEUTICAL COMPANIES, INC.	Mar 3, 2010	Sell	-100	25.25	$2.5K	SEC
PAR PHARMACEUTICAL COMPANIES, INC.	Mar 3, 2010	Sell	-400	25.26	$10.1K	SEC
PAR PHARMACEUTICAL COMPANIES, INC.	Mar 3, 2010	ExerciseD	-21,439	0.00	$0	SEC
PAR PHARMACEUTICAL COMPANIES, INC.	Mar 3, 2010	Exercise	21,439	13.06	$280K	SEC
PAR PHARMACEUTICAL COMPANIES, INC.	Mar 3, 2010	Sell	-500	25.20	$12.6K	SEC
PAR PHARMACEUTICAL COMPANIES, INC.	Mar 3, 2010	Sell	-700	25.19	$17.6K	SEC
PAR PHARMACEUTICAL COMPANIES, INC.	Mar 3, 2010	Sell	-3,261	25.19	$82.1K	SEC